SEC Filing Summary for BioStem Technologies, Inc.

This filing details transactions related to BioStem Technologies, Inc. (BSEM) as reported by Michael A. Fortunato, Chief Accounting Officer. On September 15, 2026, Fortunato acquired 4,234 shares of Common Stock with no cost basis, increasing his post-transaction holdings to 68,664 shares. Concurrently, Fortunato disposed of 4,234 Restricted Stock Units (RSUs), leaving him with 16,941 RSUs. These RSUs represent a contingent right to receive one share of the issuer's common stock upon vesting, which occurs in equal quarterly installments over three years from the grant date of September 15, 2024. The filing also provides details on various stock options held by Fortunato, with different exercise prices and expiration dates, and their respective vesting schedules.